Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Sensei Biotherapeutics Stock Price, Quotes and Forecasts | NASDAQ:SNSE | Benzinga

Q: What sector and industry does Sensei Biotherapeutics (SNSE) operate in?

Sensei Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Sensei Biotherapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SNSE.

Open	$0.32
Close	$0.37
Volume / Avg.	513.79K / 2.75M
Day Range	$0.31 - $0.37
52 Wk Range	0.25 - 1.94
Market Cap	$9.23M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	11.32%
Days to Cover	1

Recent News

Sensei Biotherapeutics Reports Favorable Initial Clinical Activity Data For Solnerstotug In Resistant Tumors

Sensei Biotherapeutics' solnerstotug shows a 14% ORR in PD-(L)1 resistant tumors and remains well tolerated in early trial data from its Phase 1/2 study.

Vandana Singh

US Stocks Likely To Open Lower, Analysts Warn 'Prolonged Uncertainty Could Hurt Both US And Global Risk Assets'

U.S. stock futures fell on Friday after two consecutive days of decline on Wednesday and Thursday. Futures of benchmark indices were lower.

Rishabh Mishra

Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.32
Close	$0.37
Volume / Avg.	513.79K / 2.75M
Day Range	$0.31 - $0.37
52 Wk Range	0.25 - 1.94
Market Cap	$9.23M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	11.32%
Days to Cover	1

About Sensei Biotherapeutics Inc

Sector

Health Care

Industry

Biotechnology

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of...

Got Questions? Ask

How is SNSE's EV/EBITDA ratio?

What is SNSE's 5 years max drawdown?

What is SNSE's operating cash flow?

What’s driving SNSE's recent performance?

What’s the latest news on SNSE?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Sensei Biotherapeutics (SNSE) stock?

You can purchase shares of Sensei Biotherapeutics (NASDAQ:SNSE) through any online brokerage.

View our list of the best stock brokerages

Who are Sensei Biotherapeutics (SNSE) competitors?

Other companies in Sensei Biotherapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Acurx Pharmaceuticals (NASDAQ:ACXP), CARISMA Therapeutics (NASDAQ:CARM), Evaxion Biotech (NASDAQ:EVAX) and Can Fite Biofarma (AMEX:CANF).

What is the forecast, or price target, for Sensei Biotherapeutics (SNSE) stock?

Sensei Biotherapeutics has a consensus price target of $4.25.

What is the current price for Sensei Biotherapeutics (SNSE)?

The stock price for Sensei Biotherapeutics (NASDAQ: SNSE) is $0.367 last updated April 11, 2025 at 7:42 PM EDT.

Does Sensei Biotherapeutics (SNSE) pay a dividend?

There are no upcoming dividends for Sensei Biotherapeutics.

When is Sensei Biotherapeutics (NASDAQ:SNSE) reporting earnings?

Sensei Biotherapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Sensei Biotherapeutics (SNSE) going to split?

There is no upcoming split for Sensei Biotherapeutics.

What sector and industry does Sensei Biotherapeutics (SNSE) operate in?

Sensei Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Sensei Biotherapeutics Stock Price, Quotes and Forecasts

Sensei Biotherapeutics (SNSE) Forecast